BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23603411)

  • 1. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats.
    Li R; Zheng N; Liang T; He Q; Xu L
    Brain Res; 2013 Jun; 1517():28-35. PubMed ID: 23603411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.
    Sun SY; An CN; Pu XP
    Brain Res Bull; 2012 Sep; 88(6):609-16. PubMed ID: 22664331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats.
    Song S; Nie Q; Li Z; Du G
    Pathol Res Pract; 2016 Apr; 212(4):247-51. PubMed ID: 26922613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway.
    Li R; Liang T; Xu L; Zheng N; Zhang K; Duan X
    Brain Res; 2013 Jul; 1523():1-9. PubMed ID: 23747813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Pan X; Chen C; Huang J; Wei H; Fan Q
    Neurosci Lett; 2015 Jul; 600():220-5. PubMed ID: 26101828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism.
    Jalali-Nadoushan M; Roghani M
    Brain Res; 2013 Apr; 1505():68-74. PubMed ID: 23415934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat.
    Yu YP; Ju WP; Li ZG; Wang DZ; Wang YC; Xie AM
    Brain Res; 2010 Jun; 1336():58-65. PubMed ID: 20399757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage.
    Liu X; Shao R; Li M; Yang G
    Cell Biochem Biophys; 2014 Nov; 70(2):1247-54. PubMed ID: 24948472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models.
    Maasz G; Zrinyi Z; Reglodi D; Petrovics D; Rivnyak A; Kiss T; Jungling A; Tamas A; Pirger Z
    Dis Model Mech; 2017 Feb; 10(2):127-139. PubMed ID: 28067625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
    Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
    Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
    Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
    FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine.
    Czarnecka A; Lenda T; Domin H; Konieczny J; Smiałowska M; Lorenc-Koci E
    Brain Res; 2013 Dec; 1541():92-105. PubMed ID: 24129225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Curcumin alleviated liver oxidative stress injury of rat induced by paraquat].
    Han W; Wu D; Liu H; Lu Y; Wang L; Hong G; Qiu Q; Lu Z
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 May; 32(5):352-6. PubMed ID: 25169090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.